Cargando…

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo

Neurofibromatosis type 1 (NF1) is a common autosomal-dominant disorder characterized by cutaneous neurofibromas infiltrated with large numbers of mast cells, melanocyte hyperplasia, and a predisposition to develop malignant neoplasms. NF1 encodes a GTPase activating protein (GAP) for Ras. Consistent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingram, David A., Yang, Feng-Chun, Travers, Jeffrey B., Wenning, Mary Jo, Hiatt, Kelly, New, Sheryl, Hood, Antoinette, Shannon, Kevin, Williams, David A., Clapp, D. Wade
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195790/
https://www.ncbi.nlm.nih.gov/pubmed/10620616
_version_ 1782147927560421376
author Ingram, David A.
Yang, Feng-Chun
Travers, Jeffrey B.
Wenning, Mary Jo
Hiatt, Kelly
New, Sheryl
Hood, Antoinette
Shannon, Kevin
Williams, David A.
Clapp, D. Wade
author_facet Ingram, David A.
Yang, Feng-Chun
Travers, Jeffrey B.
Wenning, Mary Jo
Hiatt, Kelly
New, Sheryl
Hood, Antoinette
Shannon, Kevin
Williams, David A.
Clapp, D. Wade
author_sort Ingram, David A.
collection PubMed
description Neurofibromatosis type 1 (NF1) is a common autosomal-dominant disorder characterized by cutaneous neurofibromas infiltrated with large numbers of mast cells, melanocyte hyperplasia, and a predisposition to develop malignant neoplasms. NF1 encodes a GTPase activating protein (GAP) for Ras. Consistent with Knudson's “two hit” model of tumor suppressor genes, leukemias and malignant solid tumors in NF1 patients frequently demonstrate somatic loss of the normal NF1 allele. However, the phenotypic and biochemical consequences of heterozygous inactivation of Nf1 are largely unknown. Recently neurofibromin, the protein encoded by NF1, was shown to negatively regulate Ras activity in Nf1−/− murine myeloid hematopoietic cells in vitro through the c-kit receptor tyrosine kinase (dominant white spotting, W). Since the W and Nf1 locus appear to function along a common developmental pathway, we generated mice with mutations at both loci to examine potential interactions in vivo. Here, we show that haploinsufficiency at Nf1 perturbs cell fates in mast cells in vivo, and partially rescues coat color and mast cell defects in W(41) mice. Haploinsufficiency at Nf1 also increased mast cell proliferation, survival, and colony formation in response to Steel factor, the ligand for c-kit. Furthermore, haploinsufficiency was associated with enhanced Ras–mitogen-activated protein kinase activity, a major downstream effector of Ras, via wild-type and mutant (W(41)) c-kit receptors. These observations identify a novel interaction between c-kit and neurofibromin in vivo, and offer experimental evidence that haploinsufficiency of Nf1 alters both cellular and biochemical phenotypes in two cell lineages that are affected in individuals with NF1. Collectively, these data support the emerging concept that heterozygous inactivation of tumor suppressor genes may have profound biological effects in multiple cell types.
format Text
id pubmed-2195790
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21957902008-04-16 Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo Ingram, David A. Yang, Feng-Chun Travers, Jeffrey B. Wenning, Mary Jo Hiatt, Kelly New, Sheryl Hood, Antoinette Shannon, Kevin Williams, David A. Clapp, D. Wade J Exp Med Brief Definitive Report Neurofibromatosis type 1 (NF1) is a common autosomal-dominant disorder characterized by cutaneous neurofibromas infiltrated with large numbers of mast cells, melanocyte hyperplasia, and a predisposition to develop malignant neoplasms. NF1 encodes a GTPase activating protein (GAP) for Ras. Consistent with Knudson's “two hit” model of tumor suppressor genes, leukemias and malignant solid tumors in NF1 patients frequently demonstrate somatic loss of the normal NF1 allele. However, the phenotypic and biochemical consequences of heterozygous inactivation of Nf1 are largely unknown. Recently neurofibromin, the protein encoded by NF1, was shown to negatively regulate Ras activity in Nf1−/− murine myeloid hematopoietic cells in vitro through the c-kit receptor tyrosine kinase (dominant white spotting, W). Since the W and Nf1 locus appear to function along a common developmental pathway, we generated mice with mutations at both loci to examine potential interactions in vivo. Here, we show that haploinsufficiency at Nf1 perturbs cell fates in mast cells in vivo, and partially rescues coat color and mast cell defects in W(41) mice. Haploinsufficiency at Nf1 also increased mast cell proliferation, survival, and colony formation in response to Steel factor, the ligand for c-kit. Furthermore, haploinsufficiency was associated with enhanced Ras–mitogen-activated protein kinase activity, a major downstream effector of Ras, via wild-type and mutant (W(41)) c-kit receptors. These observations identify a novel interaction between c-kit and neurofibromin in vivo, and offer experimental evidence that haploinsufficiency of Nf1 alters both cellular and biochemical phenotypes in two cell lineages that are affected in individuals with NF1. Collectively, these data support the emerging concept that heterozygous inactivation of tumor suppressor genes may have profound biological effects in multiple cell types. The Rockefeller University Press 2000-01-03 /pmc/articles/PMC2195790/ /pubmed/10620616 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Ingram, David A.
Yang, Feng-Chun
Travers, Jeffrey B.
Wenning, Mary Jo
Hiatt, Kelly
New, Sheryl
Hood, Antoinette
Shannon, Kevin
Williams, David A.
Clapp, D. Wade
Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title_full Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title_fullStr Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title_full_unstemmed Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title_short Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
title_sort genetic and biochemical evidence that haploinsufficiency of the nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195790/
https://www.ncbi.nlm.nih.gov/pubmed/10620616
work_keys_str_mv AT ingramdavida geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT yangfengchun geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT traversjeffreyb geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT wenningmaryjo geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT hiattkelly geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT newsheryl geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT hoodantoinette geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT shannonkevin geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT williamsdavida geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo
AT clappdwade geneticandbiochemicalevidencethathaploinsufficiencyofthenf1tumorsuppressorgenemodulatesmelanocyteandmastcellfatesinvivo